Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2010
06/10/2010US20100143444 Peptides and peptide mimetics to treat pathologies associated with eye disease
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143349 Humanized anti-rage antibody
06/10/2010US20100143346 Treatment of Macular Degeneration
06/10/2010US20100143328 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
06/10/2010CA2745832A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/09/2010EP2194044A1 Quinolone derivative
06/09/2010EP2193806A1 Agent for promoting corneal endothelial cell adhesion
06/09/2010EP2193795A1 Latanoprost-containing aqueous pharmaceutical composition
06/09/2010EP2192915A1 Therapeutic uses of peptides ysaypdsvpmms and wmnstgftkvcgappc
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010EP1385864B1 Anti-VEGF-2 antibodies
06/09/2010EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis
06/09/2010CN1824064B Use of composition in preparing nutrients with edible and medicinal function for treating pseudomyopia
06/09/2010CN1824062B Use of Chinese medicinal composition for preparing product for preventing and treating pseudomyopia
06/09/2010CN1824057B Use of Chinese and western medicine combined composition for preparing product with edible and medicine function for treating nightblindness
06/09/2010CN1824052B Use of composition in preparing product for preventing pseudomyopia and true myopia
06/09/2010CN1824051B Use of composition in preparing product for preventing pseudomyopia and true myopia
06/09/2010CN101730690A Sulfonamide compound, and crystal thereof
06/09/2010CN101724653A Medicament containing natriuretic peptide gene as well as preparation method and application thereof
06/09/2010CN101721701A Crystallization of antibodies or fragments thereof
06/09/2010CN101721591A Health-care product
06/09/2010CN101721526A medicine for treating keratitis
06/09/2010CN101721431A Compound nano pearl starch ball and production process thereof
06/09/2010CN101721363A Cefixime oral administration mixed suspension and preparation method thereof
06/09/2010CN101721358A Eye drops containing recombinant human keratinocyte growth factor-2 and application thereof in treating xeroma
06/09/2010CN101721354A Ocular implant made by a double extrusion process
06/09/2010CN101720930A Notoginseng flower liver-nourishing and visual acuity improving tea and preparation thereof
06/09/2010CN101385703B Cation adhesion type natamycin nano eye drops
06/09/2010CN101259098B Long-acting low molecule heparin intraocular sustained-release system
06/09/2010CN101073599B Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
06/09/2010CN101028240B Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732455 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732425 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome
06/08/2010US7732415 Topical treatment or prevention of ocular infections
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/03/2010WO2010062905A2 Lateral ventricle cell compositions and use for treating neural degenerative diseases
06/03/2010WO2010062523A2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
06/03/2010WO2010062413A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010060934A2 Cnnm proteins and uses thereof
06/03/2010WO2010060768A1 Polypeptides, antibody variable domains & antagonists
06/03/2010US20100137364 6-Aminoisoquinoline Compounds
06/03/2010US20100137347 5-[3-((1S,2R)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-methylene-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester; glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137301 Substituted Indolealkanoic Acids
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137252 Ophthalmic composition
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/03/2010US20100135953 Method of treatment of age-related macular degeneration
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2744055A1 Polypeptides, antibody variable domains & antagonists
06/02/2010EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010DE102008059201A1 In situ präzipitierende Arzneistofflösungen In situ precipitating drug solutions
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101716255A Medicinal composition with function of protecting optic nerve and preparation method and application thereof
06/02/2010CN101716248A Traditional Chinese medicine composition for treating diabetes mellitus
06/02/2010CN101716244A Preparation and process of qingkailing eye drops
06/02/2010CN101716243A Qingkailing gelling agent for eyes and preparation method thereof
06/02/2010CN101716200A Medicinal composition for invigorating circulation blood and dredging collaterals and clearing heat and releasing toxin and preparation method and application thereof
06/02/2010CN101716144A Lutein-hydrogenated phospholipid liposome precursor and preparation method thereof
06/02/2010CN101716133A Aseculin ophthalmic gel and production method and application thereof
06/02/2010CN101181253B Chloromycetin eyedrops with long shelf-life and preparation method thereof
06/02/2010CN101181252B Chloromycetin eyedrops with long shelf-life and preparation method thereof
06/02/2010CN101167884B Orally-administered traditional Chinese medicinal formula for treating cataract
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2490120C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
06/01/2010CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/01/2010CA2443456C Novel atisane compounds and use thereof
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010060088A2 Pathways to generate hair cells
05/27/2010WO2010059858A1 Manassantin compounds and methods of making and using same
05/27/2010WO2010058795A1 Antioxidant
05/27/2010WO2010058794A1 Antioxidant
05/27/2010WO2010058779A1 Therapeutic agent for chorioretinal degenerative diseases comprising pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
05/27/2010WO2010058166A1 Use of rimcazole for the treatment of ocular disorders
05/27/2010WO2010017626A4 Compositions comprising terpene compounds for treating negative sensory phenomena
05/27/2010US20100130621 Use of hydroxytyrosol as anti-aging agent
05/27/2010US20100130620 Novel use of hydroxytyrosol and olive extracts/concentrates containing it
05/27/2010US20100130580 Formulations and Methods for Treating Dry Eye
05/27/2010US20100130572 Cytoskeletal active compounds, composition and use
05/27/2010US20100130569 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 531